Psyence Group Inc (GCR)

Currency in CAD
0.980
+0.910(+1,308.05%)
Closed·
Trading near 52-week High
GCR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.9800.980
52 wk Range
0.1100.980
Key Statistics
Prev. Close
0.01
Open
0.98
Day's Range
0.98-0.98
52 wk Range
0.11-0.98
Volume
100
Average Volume (3m)
100
1-Year Change
476.4706%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GCR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Earnings

Latest Release
Jul 24, 2026
EPS / Forecast
-0.07 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

GCR Income Statement

Compare GCR to Peers and Sector

Metrics to compare
GCR
Peers
Sector
Relationship
P/E Ratio
−3.0x−2.7x−0.4x
PEG Ratio
-0.000.00
Price/Book
-−3.9x2.6x
Price / LTM Sales
-2.7x3.1x
Upside (Analyst Target)
-80.0%48.5%
Fair Value Upside
Unlock−1.3%5.8%Unlock

As of July 27, 2026, Psyence Group Inc. was acquired by GoldCoast Resource Corp., in a reverse merger transaction. Psyence Group Inc., a life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma. It operates in two segments, Clinical Trial Activities and Non-Clinical Trial Activities. The company develops botanical psilocybin-based psychedelic medicine, which works with natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. It also focuses on the research and development, cultivation, and production of psilocybin mushrooms and functional over-the-counter mushroom products. The company offers its functional mushroom products under the GOODMIND brand. Psyence Group Inc. was founded in 2019 and is based in Toronto, Canada.

FAQ

What Is the Psyence (GCR) Stock Price Today?

The Psyence stock price today is 0.980 CAD.

What Stock Exchange Does Psyence Trade On?

Psyence is listed and trades on the CBOE Canada Exchange.

What Is the Stock Symbol for Psyence?

The stock symbol for Psyence is "GCR."

What Is the Psyence Market Cap?

As of today, Psyence market cap is 1.940M CAD.

What Is Psyence's Earnings Per Share (TTM)?

The Psyence EPS (TTM) is -0.090.

From a Technical Analysis Perspective, Is GCR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Psyence Stock Split?

Psyence has split 2 times.

What is the current trading status of Psyence (GCR)?

As of Aug 10, 2026, Psyence (GCR) is trading at a price of 0.980 CAD, with a previous close of 0.010 CAD. The stock has fluctuated within a day range of 0.980 CAD to 0.980 CAD, while its 52-week range spans from 0.110 CAD to 0.980 CAD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.